In addition, we detected that PF-06409577 significantly eliminated the increases in the expression levels of IL-6, IL-1β and TNF-α induced by co-treatment with MWCNTs and PbAc in NAFLD mice livers. Here, IL1B is linked to metabolic dysfunction-associated steatotic liver disease.